Previous Article | Next Article ![]()
Journal of Bacteriology, August 1999, p. 4873-4878, Vol. 181, No. 16
Institute of Medical Microbiology and
Virology and Center for Biological and Medical Research,
Heinrich-Heine-University, 40225 Duesseldorf, Germany
Received 23 November 1998/Accepted 1 June 1999
Mycoplasma hominis, a cell-wall-less prokaryote, was
shown to be cytoadherent by the participation of a 100-kDa membrane
protein (P100). To identify the gene encoding P100, peptides of P100
were partially sequenced to enable the synthesis of P100-specific
oligonucleotides suitable as probes for the detection of the P100 gene.
With this strategy, we identified a genomic region of about 10.4 kb in
M. hominis FBG carrying the P100 gene. Analysis of the
complete deduced protein sequence suggests that P100 is expressed as a
pre-lipoprotein with a structure in the N-terminal region common to
peptide-binding proteins and an ATP- or GTP-binding P-loop structure in
the C-terminal region. Downstream of the P100 gene, an additional four
open reading frames putatively encoding the four core domains of an
active transport system, OppBCDF, were localized. The organization of the P100 gene and oppBCDF in a transcriptionally active
operon structure was demonstrated in Northern blot and reverse
transcription-PCR analyses, as all gene-specific probes detected a
common RNA of 9.5 kb. Primer extension analysis revealed that the
transcriptional initiation site was localized 323 nucleotides upstream
of the methionine-encoding ATG of the P100 gene. The peptide-binding character of the P100 protein was confirmed by fluorescence
spectroscopy and strongly suggests that the cytoadherence-mediating
lipoprotein P100 represents OppA, the substrate-binding domain of a
peptide transport system in M. hominis.
Mycoplasmas are the smallest living
prokaryotes. Because of their small genome, they do not have the
capacity to synthesize molecules such as cholesterol, fatty acids, some
amino acids, purines, and pyrimidines. The absence of such synthesis
pathways determines the parasitic behavior of mycoplasmas, which is
characterized by the uptake of essential products from the host cell
(4, 34).
The transport of proteins through the cell membrane is mediated by the
secretory pathway (46). To date, a small number of systems
for the active transport of sugars, amino acids, K+, and
Na+ through the membrane in mycoplasmas have been studied
in detail, but the molecular basis of such transport to a large extent
remains to be determined (33). In both prokaryotes and
eukaryotes, the superfamily of ABC (ATP-binding cassette) transporters
has been found to be responsible for the export of proteases,
hemolysin, and polysaccharides and the import of sugars, inorganic
ions, and di-, tri-, and oligopeptides (19, 20, 26, 32, 45).
For Mycoplasma hyorhinis, a binding-protein component of a
putative binding-protein-dependent transport system belonging to the
ABC superfamily (9, 13) was characterized as a 37-kDa protein that was found to influence tumor cell invasiveness in vitro
(42). Sequencing of the genomes of Mycoplasma
pneumoniae (24) and Mycoplasma genitalium
(12) indicated the presence in mycoplasmas of a further ABC
transporter that has been proposed to be responsible for the import of
oligopeptides. This oligopeptide permease (Opp) system has been
extensively characterized for Salmonella typhimurium
(22, 23, 36, 44) and Bacillus subtilis (30, 37).
For Mycoplasma hominis, a facultative urogenital tract
pathogen (31), a number of membrane proteins have been
described (7, 16, 35); however, little is known about their
function. Two proteins (P50 and P100) were identified to be associated
with mycoplasmal adherence to host cells (15). In this
paper, we show the peptide-binding character of the P100 lipoprotein
and demonstrate that the P100 gene is organized within an operon
structure containing genes putatively encoding the core domains of an
ABC transporter. These findings suggest that P100 functions as the substrate-binding domain OppA of an oligopeptide permease of M. hominis.
Mycoplasma culture conditions.
M. hominis FBG was
grown in PPLO broth base medium containing arginine as described
previously (3, 11). Stocks of isolate FBG were prepared from
a mid-logarithmic-phase broth culture and stored at Bacterial strains and plasmids.
pT7T3-19U (Pharmacia
Biotech, Freiburg, Germany) was used as a cloning vector for the
construction of recombinant plasmids with different genomic
opp fragments. The plasmids were propagated in
Escherichia coli DH5 Oligonucleotides.
Oligonucleotides were synthesized with a
solid carrier on an Applied Biosystems 381A machine by the
phosphoamidite method (5). The antisense oligonucleotide
P100-1 [5'-CAT(A/G)TA(T/A/C)A(A/G)TTG(A/T)GG(A/T)GC(G/A)TTTA-3'] and the sense oligonucleotide P100-2
[5'-GTTGG(A/ T ) T T T (A/C)GA T A(C/ T ) T T AAA T GC(A/ T )CC(A/ T )CAA T T ATATATG - 3']
were used as probes in Southern blot analysis. The primers
P100-pe1 (5'-GGA CCC AAG ACC AAG TAA TCA TAA-3'), P100-pe2 (5'-TAC ATG AAG CGG CTA CTA ATC-3'), and oppB-pe1 (5'-ACG CTA TTC TTT
GTA ATA TAT ATT TTG TCA-3') were used in primer extension analysis.
DNA and RNA manipulations.
Genomic mycoplasmal DNA was
isolated by use of a QIAamp Tissue Kit (Qiagen, Hilden, Germany) as
described previously (17). All further DNA techniques were
carried out by standard procedures (38, 39, 43) or by
following the instructions of the commercial suppliers of materials.
RNA from exponential-phase cultures of M. hominis FBG was
prepared by the single-step method of Chomczynski and Sacchi
(6).
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Adherence-Associated Lipoprotein P100, Encoded
by an opp Operon Structure, Functions as the
Oligopeptide-Binding Domain OppA of a Putative Oligopeptide Transport
System in Mycoplasma hominis
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C.
F' (Gibco BRL, Gaithersburg, Md.).
Reverse transcription-PCR.
Before M. hominis RNA
was used as a template in reverse transcription-PCR, contaminating
traces of DNA were digested with 0.6 U of DNase I (Roche Molecular
Biochemicals) per µg of nucleic acid in 50 mM Tris-HCl (pH 8.3)-75
mM KCl-3 mM MgCl2 for 15 min at 37°C. RNA was reverse
transcribed by use of a 1st-Strand cDNA Synthesis Kit (Clontech
Laboratories, Inc.). With this cDNA as a template, gene-overlapping
opp regions were amplified by standard PCR conditions
(initial cycle of 2 min at 94°C and then 1 min at 94°C, 1.5 min at
Tm
2°C, and 1 min at 72°C, for a total of 34 cycles) with PCR reagents from Perkin-Elmer Cetus (Überlingen, Germany) or AGS (Heidelberg, Germany).
Primer extension analysis. Primers P100-pe1, P100-pe2, and oppB-pe1 were labeled with [32P]dATP, annealed to 10 µg of M. hominis RNA, and extended with avian myeloblastoma virus reverse transcriptase as described by Ayer and Dynan (2). With the same primers, genomic DNA sequencing reactions were performed, and samples were separated on an 8% polyacrylamide-8 M urea gel next to the primer extension products.
Sequence analysis. The analysis of DNA and protein sequences and the design of oligonucleotides were facilitated by use of the computer program Lasergene (DNASTAR Inc., Madison, Wis.). Distant relationships to other proteins were determined by use of Psi-blast (34a). The protein sequences of OppABCDF of other species were drawn from the Swissprot database of EMBL: M. genitalium, P47563, P47323, P47324, P47325, and P47326; M. pneumoniae, P75327, P75554, P75553, P75552, and P75551; B. subtilis, P24141, P24138, P24139, P24136, and P24137; S. typhimurium, P06202, P08006, P08066, P04285, and P08007; and Haemophilus influenzae, P44572, P45054, P45053, P45052, and P45051.
Fluorescence spectroscopy.
The P100 protein was solubilized
from the membrane with 0.5%
n-dodecyl-
-D-maltoside (ICN Biomedical,
Eschwege, Germany) in phosphate-buffered saline (pH 7.3) and purified
by affinity chromatography by a procedure described earlier
(15). Fluorescence spectra were determined with a Shimadzu
RF-5001PC spectrofluorometer. An excitation slit of 3 nm and an
emission slit of 5 nm were used for the emission spectra. All
measurements were obtained with 0.15 µM P100 (0.15 mg/ml) after
dialysis against 10 mM imidazole acetate (pH 7.3)-100 mM NaCl-0.03%
n-dodecyl-
-D-maltoside (for analyzing
Lys3 or Ala3) or 10 mM sodium phosphate (pH
7.0)-0.03% n-dodecyl-
-D-maltoside (for
analyzing Ala5 or Ala3) in the presence or
absence of the respective peptide at a final concentration of 100 µM.
With an excitation wavelength of 290 nm, fluorescence emission was
monitored from 300 to 430 nm at room temperature.
Nucleotide sequence accession number. The P100- and OppBCDF-encoding sequence of M. hominis FBG has been assigned EMBL accession no. X99740.
| |
RESULTS |
|---|
|
|
|---|
opp gene sequences.
A 100-kDa membrane protein of
M. hominis (P100) was shown to be species specific and
involved in cytoadherence of the organism (15). To
characterize the P100-encoding gene, the P100 protein of M. hominis FBG was purified by affinity chromatography, and the
N-terminal amino acids of a V8 protease-generated P100 peptide were
determined by an Edman reaction (10). From this peptide, P100-1 (V-G-F-R-Y-L-N-A-P-Q-L-Y-M), the oligonucleotides P100-1 and
P100-2 were deduced, characterized by low degeneration and a preference
for AT-enriched codon usage (see Materials and Methods), and used as
probes in Southern blot analysis. Both probes detected a 3-kb
HindIII DNA fragment of M. hominis FBG.
Cloning and sequencing of this fragment revealed that it encodes the
C-terminal part of P100, including the 13 amino acids (aa) of peptide
P100-1. This 3-kb fragment and overlapping DNA fragments were
hybridized to restricted genomic DNA, followed by cloning and
sequencing of the detected DNA fragments. Finally, a 10.4-kb genomic
region of M. hominis FBG was sequenced (Fig.
1); this region contains the entire P100
gene sequence and a putative ribosomal binding site (AAGGA) 10 bp
upstream of the translational start codon ATG. The deduced polypeptide
chain of P100 starts with an N-terminal signal sequence of 28 aa which
meets all the requirements of a transmembrane helix (from aa 7 to aa
26) and of a signal peptidase II recognition site [(
4)-VAASC-(+1)]
with a lipoprotein attachment site at position 28 (in bold)
(LVAASCKIDPA). Thus, P100 seems to be a cysteine-anchored
lipoprotein of M. hominis which is expressed as a precursor
polypeptide.
|
Five genes and one mRNA. Genes encoding the domains of an active transport system are polycistronically transcribed in B. subtilis (30) and S. typhimurium (1, 23, 36). As described above, the three regions between the P100 gene and oppD contained only a few nucleotides, and the oppD and oppF genes even overlapped by 4 bp. Purine-enriched regions, which are characteristic for ribosomal binding sites, were detected 10 bp upstream of the P100 gene, 14 bp upstream of the oppC gene, 16 bp upstream of oppD, and 10 bp upstream of oppF. No oppB-specific ribosomal binding site was detected.
In order to elucidate the organization of the five genes of M. hominis, the P100 gene and oppBCDF, we analyzed their expression at the mRNA level (see Materials and Methods). Five DNA probes, each detecting one of the five genes, were generated. As shown in Fig. 2, each probe detected an mRNA of 9.5 kb. Furthermore, the P100-specific probe hybridized to mRNAs of 3.3 and 2.2 kb. The mRNA of 2.2 kb seemed to be a degradation product of the 3.3-kb mRNA, as in some experiments a decrease in the signal intensity at 3.3 kb resulted in an increase in the signal intensity at 2.2 kb (data not shown). The detection of three hairpin loops downstream of the P100 gene may be responsible for the termination of mRNA at 3.3 kb. This result suggests alternative P100 gene expression
either independent of or concomitant with that of the other
opp genes of the operon structure.
|
5' Mapping of the opp mRNA. The transcriptional initiation site for the 9.5-kb mRNA was determined by primer extension. Three antisense oligonucleotide primers were used: P100-pe1 and P100-pe2, annealing to the N-terminus-encoding region of the P100 gene, and oppB-pe1, annealing to the 5' end of oppB. No distinct product was obtained by use of oppB-pe1, whereas with both P100 primers, the 5' end of the mRNA was mapped to a guanosine at nucleotide 307 (Fig. 3), thus indicating that the polycistronic mRNA initiates 323 nucleotides upstream of the translational start codon of the P100 gene.
|
Characterization of P100 as the oligopeptide-binding protein OppA. After the demonstration that the P100 gene and oppBCDF of M. hominis are organized within a transcriptionally active operon structure, we wanted to analyze whether P100 is part of the proposed oligopeptide permease of M. hominis. Like the experiments of Guyer and coworkers in characterizing the binding specificity of OppA of E. coli (14), we tested the peptide-binding capacity of P100 by spectrofluorometry. With 16 internal tryptophan residues, P100 exhibited excellent native tryptophan fluorescence when excited at 290 nm, with an emission maximum at 330 nm (Fig. 4). The addition of Lys3 resulted in a substantial increase in tryptophan fluorescence and in a red shift of 1.6 nm of the emission maximum caused by conformational changes when the peptide was bound. The addition of the same volume of buffer resulted in a decrease in tryptophan fluorescence due to a dilution effect. Thus, the fluorescence increased by about 7% after peptide binding, confirming that P100 is an oligopeptide-binding protein. The fluorescence emission spectra of bovine serum albumin and carbonic anhydrase, used as controls, were not increased after the addition of Lys3; the spectra remained unchanged for carbonic anhydrase and decreased for bovine serum albumin, as was observed after the addition of buffer alone. As has been shown for OppA of E. coli, we also did not observe a reproducible increase in the emission spectrum with Ala3 as a substrate; however, with the pentapeptide Ala5, we observed the same increase in tryptophan fluorescence as that depicted with Lys3 in Fig. 4.
|
| |
DISCUSSION |
|---|
|
|
|---|
Mycoplasmas are restricted to parasitic behavior because of their small genome size. Thus, ABC transport systems play an important role in the uptake of essential substrates, including sugars, proteins, and peptides.
The proposed Opp transport system of M. hominis described here displayed little overall sequence similarity with the respective domains of other species but shared their typical features: it is composed of the four core domains OppBCDF and the cytoadherence-associated lipoprotein P100 as the substrate-binding domain OppA. The homologies of the hydrophobic integral domains OppB and OppC were greater when the regions which are thought to interact with the ATP-binding domains were compared. Both domains were predicted from their sequences to cross the membrane six times, forming a pore which has 12 transmembrane segments and which has been predicted to be generally required for the transport of substrates (oligopeptides) through the membrane (21, 23). In addition, they carry in their C-terminal portions a conserved hydrophilic segment which is found in bacterial binding-protein-dependent permeases (40). The conserved nature of these functionally important structures in the hydrophobic Opp domains of M. hominis is a characteristic feature of active genes.
The two ATP-binding domains, OppD and OppF, showed homologies to the respective domains of the other species of up to 41.9%. This result is in good agreement with the finding that, in general, the ATP-binding domains show sequence identity of 30 to 50% and are thus more homologous than the respective integral domains of the transport system (18, 21). The greater homology detected for the ATP-binding sites indicates once more the selection pressure on functionally important structures of the permease system. A common feature of mycoplasma OppF domains seems to be their larger size (Fig. 1): in comparison with nonmycoplasma OppF domains, which have molecular masses of about 36 kDa, they have calculated molecular masses of about 98 kDa. What consequences this size difference may have on the function of the transporter remains to be elucidated.
In gram-negative bacteria, three distinct permease systems have been described for the separate transport of di-, tri- and oligopeptides through the membrane (19, 22, 25), whereas only two distinct systems have been detected for translocating tetra- and tri- or pentapeptides through the membrane in B. subtilis (29, 30). For the Mollicutes class, an ABC transport system that was well characterized at the protein level for M. hyorhinis was similar to that analyzed for gram-positive and -negative bacteria (9, 13). Based on genomic analyses, the presence of an ABC transporter for oligopeptides was proposed for M. pneumoniae (24) and M. genitalium (12), and this transporter should consist of the four core domains OppBCDF. However, the oppA gene has not been described for these two species.
As a P100-deficient mutant has never been described in the literature, has not been detected among our collection of isolates, and could not be generated by incubating M. hominis with P100-specific monoclonal antibodies, we speculate that P100 is essential for M. hominis. Thus, the question arises as to whether OppA is generally dispensable in mycoplasmas or is simply less conserved, thus rendering its identification more difficult (23, 41). The findings presented in this paper may support the latter notion, as we (i) identified the surface-localized lipoprotein P100 as the oligopeptide-binding protein OppA in M. hominis, (ii) demonstrated that the P100 gene is polycistronically organized with oppBCDF, and (iii) detected the OppA-encoding genes of M. pneumoniae and M. genitalium in homology searches with a P100 region conserved in many peptide-binding proteins. The presence of P100 as part of the Opp transporter was supported by Northern blot analysis, in which a P100 gene-less mRNA of the opp operon was never detected.
To prove the hypothesis that the cytoadhesive lipoprotein P100 functions as the substrate-binding domain OppA in the proposed oligopeptide permease of M. hominis, we tested the peptide-binding capability of solubilized P100 by spectrofluorometry by the procedure of Guyer and coworkers (14). In contrast to OppA from E. coli, which they studied, we had to deal with the disadvantage of P100 carrying a lipid moiety. Thus, it was difficult to isolate functionally active and detergent-free P100, and nearly every third preparation failed to react. Nevertheless, we were able to demonstrate the binding of tri- and pentapeptides to P100 by spectrofluorometry and to confirm the interaction of P100 with different peptides by bimolecular interaction analysis. The fact that P100 binds peptides of different lengths could endow the transporter with a less restrictive substrate specificity.
That the cytoadherence-mediating P100 protein also functions as an oligopeptide-binding domain of M. hominis corresponds to findings that the adherence of other organisms can be affected by mutations in distinct domains of the permease complex (8, 27, 28). Cundell and coworkers found that mutations in the peptide-binding proteins of the transport system of Streptococcus pneumoniae led to a reduction of bacterial affinity for the host (8). The adherence of Streptococcus gordonii was affected by the peptide-binding protein SarA as well as by mutations in the oppC gene (27, 28). Thus, both the oligopeptide-binding proteins and the entire oligopeptide transport system can be involved in bacterial adhesion, which we will now analyze at the protein level for M. hominis.
| |
ACKNOWLEDGMENTS |
|---|
We thank Marzena Czarna for excellent technical assistance; Colin MacKenzie for critically reading the manuscript; Heiner Schaal for the primer synthesis; and Friedrich W. Herberg, Institute for Physiological Chemistry, and Edda Ballweber, Institute for Anatomy and Embryology, of the medical faculty of Ruhr-University Bochum for making the BIAcore apparatus and the spectrofluorometer available.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Moorenstrasse 5, Heinrich-Heine-University, 40225 Duesseldorf, Germany. Phone: 49 211-811 5206. Fax: 49 211-811 5323. E-mail: Birgit.Henrich{at}uni-duesseldorf.de.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ames, G. F.-L. 1996. Bacterial periplasmic transport system: structure, mechanism, and evolution. Annu. Rev. Biochem. 55:397-425[Medline]. |
| 2. |
Ayer, D. E., and W. S. Dynan.
1988.
Simian virus 40 major late promotor: a novel tripartite structure that includes intragenic sequences.
Mol. Cell. Biol.
8:2021-2033 |
| 3. | Blazek, R., K. Schmitt, U. Krafft, and U. Hadding. 1990. Fast and simple procedure for the detection of cell culture mycoplasmas using a single monoclonal antibody. J. Immunol. Methods 131:203-212[Medline]. |
| 4. | Brandis, H., H. J. Eggers, W. Köhler, and G. Pulverer. 1994. Mycoplasmataceae, Mykoplasma-Erkrankungen, p. 610-617. In Lehrbuch der medizinischen Mikrobiologie. Gustav Fischer Verlag, Stuttgart, Germany. |
| 5. | Caruthers, M. H. 1982. New methods for synthesizing deoxyoligonucleotides. Genet. Eng. 4:1-16. |
| 6. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 7. | Christiansen, G. 1992. Genetic variation in natural populations, p. 561-571. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C. |
| 8. | Cundell, D. R., B. J. Pearce, J. Sandros, A. M. Naughton, and H. R. Masure. 1995. Peptide permease of Streptococcus pneumoniae affects adherence to eukaryotic cells. Infect. Immun. 63:2493-2498[Abstract]. |
| 9. | Dudler, R., C. Schmidhauser, R. W. Parish, E. H. Wetterhall, and T. Schmidt. 1988. A mycoplasma high-affinity transport system and the in vitro invasiveness of mouse sarcoma cells. EMBO J. 7:3963-3970[Medline]. |
| 10. | Edman, P., and G. Begg. 1967. A protein sequenator. Eur. J. Biochem. 1:80-91[Medline]. |
| 11. |
Feldmann, R.-C.,
B. Henrich,
V. Kolb-Bachofen, and U. Hadding.
1992.
Decreased metabolism and viability of Mycoplasma hominis induced by monoclonal antibody-mediated agglutination.
Infect. Immun.
60:166-174 |
| 12. |
Fraser, C. M.,
J. D. Gocayne,
O. White,
M. D. Adams,
R. A. Clayton,
R. D. Fleischmann,
C. J. Bult,
A. R. Kerlavage,
G. Sutton,
J. M. Kelley,
J. L. Fritschman,
J. F. Weidman,
K. V. Small,
M. Sandusky,
J. L. Fuhrmann,
D. T. Nguyen,
T. R. Utterback,
D. M. Saudek,
C. A. Phillips,
J. M. Merrick,
J.-F. Tomb,
B. A. Dougherty,
K. F. Bott,
P.-C. Hu,
T. S. Lucier,
S. N. Peterson,
H. O. Smith,
C. A. Hutchison III, and J. C. Venter.
1995.
The minimal gene complement of Mycoplasma genitalium.
Science
270:397-403 |
| 13. | Gilson, E., G. Alloing, T. Schmidt, J.-P. Clayerys, R. Dukler, and M. Hofnung. 1988. Evidence for high affinity binding protein-dependent transport systems in Gram-positive bacteria and in Mycoplasma. EMBO J. 7:3971-3974[Medline]. |
| 14. |
Guyer, C. A.,
D. G. Morgan, and J. V. Staros.
1986.
Binding specificity of the periplasmic oligopeptide-binding protein from Escherichia coli.
J. Bacteriol.
168:775-779 |
| 15. |
Henrich, B.,
R.-C. Feldmann, and U. Hadding.
1993.
Cytoadhesins of Mycoplasma hominis.
Infect. Immun.
61:2945-2951 |
| 16. | Henrich, B., A. Kitzerow, R.-C. Feldmann, H. Schaal, and U. Hadding. 1996. Repetitive elements of the Mycoplasma hominis adhesin P50 can be differentiated by monoclonal antibodies. Infect. Immun 64:4027-4034[Abstract]. |
| 17. |
Henrich, B.,
K. Lang,
A. Kitzerow,
C. MacKenzie, and U. Hadding.
1998.
Truncation as a novel form of variation of the p50 gene in Mycoplasma hominis.
Microbiology
144:2979-2985 |
| 18. | Higgins, C. F., I. D. Hiles, G. P. C. Salmond, D. R. Gill, J. A. Downie, I. J. Evans, I. B. Holland, L. Gray, S. D. Buckel, A. W. Bell, and M. A. Hermodson. 1986. A family of related ATP binding subunits coupled to many distinct biological processes in bacteria. Nature 323:448-450[Medline]. |
| 19. | Higgins, C. F., S. C. Hyde, M. L. Mimmack, U. Gileadi, D. R. Gill, and M. P. Gallagher. 1990. Binding protein-dependent transport systems. J. Bioenerg. Biomembr. 22:571-592[Medline]. |
| 20. |
Higgins, C. F.,
M. P. Gallagher,
S. C. Hyde,
M. L. Mimmack, and S. R. Pearce.
1990.
Periplasmic binding protein-dependent transport systems: the membrane associated components.
Philos. Trans. R. Soc. London Ser. B
326:353-365 |
| 21. | Higgins, C. F. 1992. ABC transporters: from microorganisms to man. Annu. Rev. Biol. 8:67-113. |
| 22. | Hiles, I. D., and C. F. Higgins. 1986. Peptide uptake by Salmonella typhimurium. The periplasmic oligopeptide-binding protein. Eur. J. Biochem. 158:561-567[Medline]. |
| 23. | Hiles, I. D., M. P. Gallagher, D. J. Jamieson, and C. F. Higgins. 1987. Molecular characterization of the oligopeptide permease of Salmonella typhimurium. J. Mol. Biol. 195:125-142[Medline]. |
| 24. |
Himmelreich, R.,
H. Hilbert,
H. Plagens,
E. Pirkl,
B. C. Li, and R. Herrmann.
1996.
Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.
Nucleic Acids Res.
24:4420-4449 |
| 25. | Hori, H., and S. Osawa. 1987. Origin and evolution of organisms as deduced from 5S ribosomal RNA sequence. Mol. Biol. Evol. 4:445-472[Abstract]. |
| 26. | Hyde, S. C., P. Emsley, M. Hartshorn, M. L. Mimmack, U. Gileadi, S. R. Pearce, M. P. Gallagher, D. R. Gill, D. R. Hubbard, and C. F. Higgins. 1990. Structural model of ATP-binding protein associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 346:362-365[Medline]. |
| 27. |
Jenkinson, H. F., and R. A. Easingwood.
1990.
Insertional inactivation of the gene encoding a 76-kilodalton cell surface polypeptide in Streptococcus gordonii Challis has a pleiotropic effect on the cell surface composition and properties.
Infect. Immun.
58:3689-3697 |
| 28. |
Jenkinson, H. F.
1992.
Adherence, coaggregation, and hydrophobicity of Streptococcus gordonii associated with expression of cell surface lipoproteins.
Infect. Immun.
60:1225-1228 |
| 29. |
Jenkinson, H. F.,
R. A. Baker, and G. W. Tannock.
1996.
A binding-lipoprotein-dependent oligopeptide transport system in Streptococcus gordonii essential for uptake of hexa- and heptapeptides.
J. Bacteriol.
178:68-77 |
| 30. | Koide, A., and J. A. Hoch. 1994. Identification of a second oligopeptide transport system in Bacillus subtilis and determination of its role in sporulation. Mol. Microbiol. 13:417-426[Medline]. |
| 31. | Krause, D. C., and D. Taylor-Robinson. 1992. Mycoplasmas which infect humans, p. 417-444. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C. |
| 32. | Kuchler, K., and J. Thorner. 1992. Secretion of peptides and proteins lacking hydrophobic signal sequences: the role of adenosine triphosphate-driven membrane translocators. Endrocrinol. Rev. 13:499-514. |
| 33. | McElhaney, R. N. 1992. Membrane function, p. 259-287. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C. |
| 34. | Miles, R. J. 1992. Cell nutrition and growth, p. 23-40. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C. |
| 34a. | National Center for Biotechnology Information. 16 September 1998, copyright date. Psi-blast. [Online.] www.ncbi.nlm.nih.gov. [9 March 1999, last date accessed.] |
| 35. |
Olson, L. D.,
S. W. Shane,
A. A. Karpas,
T. M. Cunningham,
P. S. Probst, and M. F. Barile.
1991.
Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain.
Infect. Immun.
59:1683-1689 |
| 36. | Pearce, S. R., M. L. Mimmack, M. P. Gallagher, U. Gileadi, S. C. Hyde, and C. F. Higgins. 1992. Membrane topology of the integral membrane components, OppB and OppC, of the oligopeptide permease of Salmonella typhimurium. Mol. Microbiol. 6:47-57[Medline]. |
| 37. | Perego, M., C. F. Higgins, S. R. Pearce, M. P. Gallagher, and J. A. Joch. 1991. The oligopeptide transport system of Bacillus subtilis plays a role in the initiation of sporulation. Mol. Microbiol. 5:173-185[Medline]. |
| 38. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 39. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 40. | Saurin, W., W. Köster, and E. Dassa. 1994. Bacterial binding protein-dependent permeases: characterization of distinctive signatures for functionally related integral cytoplasmic membrane proteins. Mol. Microbiol. 12:993-1004[Medline]. |
| 41. | Saurin, W., and E. Dassa. 1996. In the search of Mycoplasma genitalium lost substrate-binding proteins: sequence divergence could be the result of a broader substrate specificity. Mol. Microbiol. 22:389-391[Medline]. |
| 42. |
Schmidhauser, C.,
R. Dudler, and T. Schmidt.
1990.
A mycoplasmal protein influences tumor cell invasiveness and contact inhibition in vitro.
J. Cell Sci.
95:499-506 |
| 43. | Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517[Medline]. |
| 44. |
Speiser, D. M., and G. F.-L. Ames.
1991.
Salmonella typhimurium histidine periplasmic permease mutations that allow transport in the absence of histidine-binding protein.
J. Bacteriol.
173:1444-1451 |
| 45. |
Tam, R., and M. T. Saier.
1993.
Structural, functional, and evolutionary relationships among extracellular solute-binding receptors of bacteria.
Microbiol. Rev.
57:320-346 |
| 46. |
Verner, K., and G. Schatz.
1988.
Protein translocation across membranes.
Science
241:1307-1313 |
| 47. |
Walker, J. E.,
M. Saraste,
M. J. Runswick, and L. Gay.
1982.
Distantly related sequences in the - and -subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold.
EMBO J.
1:945-951[Medline].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»